Home > Publications Database > Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure > print

001     273978
005     20250127091347.0
024 7 _ |a pmid:39760355
|2 pmid
024 7 _ |a 10.3791/67100
|2 doi
037 _ _ |a DZNE-2024-01427
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Drude, Natascha
|b 0
245 _ _ |a Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
260 _ _ |a Cambridge, MA
|c 2024
|b JoVE
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736760000_13802
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 1940-087X not unique: **10 hits**.
520 _ _ |a The use of laboratory mice with a natural microbiome, such as 'Wildling mice', offers a promising research tool for both basic and applied science due to their close resemblance to the human superorganism. However, the breeding and maintenance of these mice, which harbor a diverse microbiome including bacteria, viruses, and parasites, pose significant challenges for animal husbandry facilities at research institutions. To address these challenges, a specialized facility concept was developed for housing 'Wildling mice' at Charité - Universitätsmedizin Berlin. This approach involved designing a facility with specific structural features and operational protocols to effectively contain the natural microbiome, thereby protecting areas with higher hygiene standards. A methodology for blood sampling from both specified pathogen-free (SPF) and 'Wildling mice' for immunophenotyping is demonstrated, highlighting the workflow and biocontainment measures implemented in the facility. Remarkable results reveal that 'Wildling mice' exposed to a natural microbiome develop distinct immune cell populations, which are significantly reduced in mice bred and maintained under stringent hygiene conditions. The significance of this study lies in its potential to provide researchers with access to mice that possess a natural microbiome and a mature immune system similar to that of human adults. This approach could enhance the translatability of preclinical findings into clinical practice, thereby advancing the field of biomedical research.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Microbiota: immunology
|2 MeSH
650 _ 2 |a Immunophenotyping: methods
|2 MeSH
650 _ 2 |a Containment of Biohazards: methods
|2 MeSH
650 _ 2 |a Animal Husbandry: methods
|2 MeSH
650 _ 2 |a Housing, Animal
|2 MeSH
700 1 _ |a Diederich, Kai
|b 1
700 1 _ |a Duerr, Claudia U.
|b 2
700 1 _ |a Haase, Nadine
|b 3
700 1 _ |a Harms, Christoph
|b 4
700 1 _ |a Heppner, Frank
|0 P:(DE-2719)2812386
|b 5
|u dzne
700 1 _ |a Jendrach, Marina
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Kahnau, Pia
|b 7
700 1 _ |a Kolesnichenko, Marina
|b 8
700 1 _ |a Lewejohann, Lars
|b 9
700 1 _ |a Kurreck, Claudia
|b 10
700 1 _ |a Lohan, Anke
|b 11
700 1 _ |a Mall, Marcus A.
|b 12
700 1 _ |a Müller, Dominik
|b 13
700 1 _ |a Nagel-Riedasch, Stefan
|b 14
700 1 _ |a Opitz, Bastian
|b 15
700 1 _ |a Schaupp, Laura
|b 16
700 1 _ |a Schönfelder, Gilbert
|b 17
700 1 _ |a Weber, Amelie
|b 18
700 1 _ |a Willimsky, Gerald
|b 19
700 1 _ |a Zang, Yalei
|b 20
700 1 _ |a Rosshart, Stephan P.
|b 21
700 1 _ |a Diefenbach, Andreas
|b 22
700 1 _ |a Jordan, Stefan
|b 23
773 _ _ |a 10.3791/67100
|g no. 214, p. 67100
|0 PERI:(DE-600)2975414-8
|n 214
|p 67100
|t JoVE science education
|v Immunology and Infection
|y 2024
|x 1940-087X
909 C O |o oai:pub.dzne.de:273978
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2812386
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JOVE-J VIS EXP : 2019
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-05-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-05-04
920 1 _ |0 I:(DE-2719)1810007
|k AG Heppner
|l Neuroimmunology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1810007
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21